Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
219
datasets available to search
ShareScore release 0.9.0
Dataset results
219 results for “new drugs”
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT04172532. IPD Sharing: YES. Countries: 1. Publications: 0.
Accessibility to New Drugs Versus SOC in Sweden
ClinicalTrials.gov study NCT03684395. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) a
ClinicalTrials.gov study NCT07340619. IPD Sharing: NO. Countries: 0. Publications: 0.
A Drug Utilisation Post-authorisation Study of New Users of Aclidinium Bromide (Monotherapy or in Combination)
ClinicalTrials.gov study NCT03333018. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Study to Assess Tolerability, Safety and Pharmacokinetics of a New Drug
ClinicalTrials.gov study NCT01702675. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Pharmacokinetics Study of a New Drug for Type 2 Diabetes
ClinicalTrials.gov study NCT02686281. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Surveillance Study of NovoRapid® for New Drug Re-examination
ClinicalTrials.gov study NCT01490112. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Investigate Effect of a New Drug (PF-00446687) in Males Suffering From Erectile Dysfunction
ClinicalTrials.gov study NCT00862888. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study to Collect and Evaluate the Safety and Efficacy Information of Korean Multiple Myeloma Patients Treated With REVLIMID®, After Approval of Marketing Authorization for New Drug in Korea
ClinicalTrials.gov study NCT02556905. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bromelain, Comosain as a New Drug for Treating and Preventing Various Types of Cancer in the Humans
ClinicalTrials.gov study NCT02340845. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study To Investigate The Ability To Use 18FDG PET Scanning To Monitor The Effectiveness Of New Drugs In COPD Patients
ClinicalTrials.gov study NCT00472264. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Post Marketing Surveillance to Collect and Evaluate the Safety and Efficacy Information of Korean MDS Patients Treated With VIDAZA®, After Approval of Marketing Authorization for New Drug in Korea
ClinicalTrials.gov study NCT02137629. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection
ClinicalTrials.gov study NCT00612898. IPD Sharing: Not stated. Countries: 11. Publications: 0.
A Phase II Clinical Trial to Study the Efficacy and Safety of a New Drug P276-00 in Treatment of Recurrent and/or Locally Advanced Head and Neck Cancer
ClinicalTrials.gov study NCT00824343. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Use of New Drug QRX-3 for Prevention and Treatment of Chronic Kidney Disease Progression
ClinicalTrials.gov study NCT06866236. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Viekira/Exviera for Korean Hepatitis C Patients According to the Standard for Re-examination of New Drugs
ClinicalTrials.gov study NCT03201718. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Trial of Observed Long-acting, Anti-HIV Treatment With a Monoclonal CCR5 Antibody (PRO 140) as an Adjunct to a New, Optimized, Oral Antiretroviral Regimen in HIV-infected Injection Drug Users With V
ClinicalTrials.gov study NCT01272258. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Comparing A New Drug Containing The Combination Meloxicam And Cyclobenzaprine In The Treatment Of Acute Lumbago
ClinicalTrials.gov study NCT01587508. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Test a New Immunotherapy, ABX-001, Alone and in Combination With the Marketed Drug, Pembrolizumab, for the Treatment of Tumors Previously Treated With Other Therapies
ClinicalTrials.gov study NCT07231458. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Monitoring Epstein-Barr Virus (EBV) Load in Rheumatoid Arthritis Patients Treated With New Immunosuppressive Drugs
ClinicalTrials.gov study NCT00947492. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.